Funding for this research was provided by:
(U01AI148069, R01 AI139761)
National Institutes of Health (R37 AI0032042, U54 GM111274)
Innovative Vector Control Consortium (DFID:30041-105)
Received: 23 July 2020
Accepted: 29 September 2020
First Online: 8 October 2020
Ethics approval and consent to participate
: This trial protocol has been approved by Emory University (IRB00108666) and the Autonomous University of Yucatan (CEI-05-2020) and endorsed by the Secretarias de Salud de Yucatan. Written consent/assent will be obtained from participants and kept in a secure place for record-keeping and trial monitor evaluation.
: The authors declare that they have no competing interests.